Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Hydration and Alkalinization is Non-Inferior to Intravenous Therapy for Prevention of Contrast Induced Nephropathy in Patients With Chronic Kidney Disease.

NCT01093131 is registered in ClinicalTrials.gov with The Western Pennsylvania Hospital as lead sponsor.

NCT NCT01093131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01093131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Hydration and Alkalinization is Non-Inferior to Intravenous Therapy for Prevention of Contrast Induced Nephropathy in Patients With Chronic Kidney Disease.
Lead sponsor
The Western Pennsylvania Hospital
Phase
Phase 4
Overall status
Withdrawn
Start date
February 28, 2005
Completion date
February 28, 2010
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast induced nephropathy